Angiopoietin-like Protein 4/8 Complex-mediated Plasmin Generation Leads to Cleavage of the Complex and Restoration of LPL Activity
Overview
Authors
Affiliations
Triglyceride (TG) metabolism is highly regulated by angiopoietin-like protein (ANGPTL) family members [Y. Q. Chen , , 1203-1220 (2020)]. During feeding, ANGPTL8 forms complexes with the fibrinogen-like domain-containing protein ANGPTL4 in adipose tissue to decrease ANGPTL3/8- and ANGPTL4-mediated lipoprotein lipase (LPL)-inhibitory activity and promote TG hydrolysis and fatty acid (FA) uptake. The ANGPTL4/8 complex, however, tightly binds LPL and partially inhibits it in vitro. To try to reconcile the in vivo and in vitro data on ANGPTL4/8, we aimed to find novel binding partners of ANGPTL4/8. To that end, we performed pulldown experiments and found that ANGPTL4/8 bound both tissue plasminogen activator (tPA) and plasminogen, the precursor of the fibrinolytic enzyme plasmin. Remarkably, ANGPTL4/8 enhanced tPA activation of plasminogen to generate plasmin in a manner like that observed with fibrin, while minimal plasmin generation was observed with ANGPTL4 alone. The addition of tPA and plasminogen to LPL-bound ANGPTL4/8 caused rapid, complete ANGPTL4/8 cleavage and increased LPL activity. Restoration of LPL activity in the presence of ANGPTL4/8 was also achieved with plasmin but was blocked when catalytically inactive plasminogen (S760A) was added to tPA or when plasminogen activator inhibitor-1 was added to tPA + plasminogen, indicating that conversion of plasminogen to plasmin was essential. Together, these results suggest that LPL-bound ANGPTL4/8 mimics fibrin to recruit tPA and plasminogen to generate plasmin, which then cleaves ANGPTL4/8, enabling LPL activity to be increased. Our observations thus reveal a unique link between the ANGPTL4/8 complex and plasmin generation.
Ghosh A, Chenier I, Leung Y, Oppong A, Peyot M, Murthy Madiraju S iScience. 2024; 27(12):111292.
PMID: 39640567 PMC: 11617963. DOI: 10.1016/j.isci.2024.111292.
Gugliucci A J Clin Med. 2024; 13(17).
PMID: 39274442 PMC: 11396212. DOI: 10.3390/jcm13175229.
Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.
Huang Y, Chen L, Li L, Qi Y, Tong H, Wu H JCI Insight. 2024; 9(13).
PMID: 38973609 PMC: 11383372. DOI: 10.1172/jci.insight.173240.
Connecting impaired fibrinolysis and dyslipidemia.
Rodriguez M, Zheng Z Res Pract Thromb Haemost. 2024; 8(3):102394.
PMID: 38706781 PMC: 11066549. DOI: 10.1016/j.rpth.2024.102394.
A unified model for regulating lipoprotein lipase activity.
Zhang R, Zhang K Trends Endocrinol Metab. 2024; 35(6):490-504.
PMID: 38521668 PMC: 11663433. DOI: 10.1016/j.tem.2024.02.016.